Akèy › Kansè (tout kalite) › Kalifòni › Santa Monica
Etid klinik pou Kansè (tout kalite) nan Santa Monica, CA
22 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Santa Monica (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 2/3
- UCLA - Santa Monica /ID# 276816, Santa Monica
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Ap rekriteFaz 1/2
- University of California at Los Angeles, Santa Monica
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
- Providence St. Johns Health Center, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Ap rekriteEtid obsèvasyon
- UCLA Medical Center, Santa Monica
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- UCLA Medical Centre-Santa Monica, Santa Monica
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- ak 1 plis
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Ap rekriteFaz 1/2
- Sarcoma Oncology Research Center, Santa Monica
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Sarcoma Oncology Center, Santa Monica
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi lwen
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Ap rekriteFaz 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Ap rekriteFaz 1
- UCLA Hematology/Oncology, Westwood, Los Angeles · 4 mi lwen
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- Providence St. John's Health Center, Santa Monica
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Ap rekriteFaz 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Ap rekriteFaz 1/2
- Precision NextGen Oncology, Beverly Hills · 6 mi lwen
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Ap rekriteFaz 1
- UCLA, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
Ap rekriteFaz 1/2
- Providence Saint John's Health Center, Santa Monica
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Santa Monica
- Kansè Poumon ki pa ti selil45 etid
- Kansè nan tete28 etid
- Kansè kolorektal23 etid
- Kansè Metastatik19 etid
- Kansè poumon15 etid
- Kansè ovè15 etid
- Kansè pwostat15 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak11 etid
- Kansè Endomèt10 etid
- Kansè lestomak9 etid
- Kansè pankreyas9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.